BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
43 results:

  • 1. Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.
    Kosumi T; Kobayashi M; Shimodaira S; Sugiyama H; Koido S
    J Med Case Rep; 2024 Feb; 18(1):88. PubMed ID: 38336778
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
    Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Desmoplastic small round cell tumor of the abdomen: A case report.
    Li R; Liu W; Ye L
    Medicine (Baltimore); 2023 Nov; 102(45):e35965. PubMed ID: 37960784
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Traditional treatment Approaches and Role of Immunotherapy in lung Malignancy and Mesothelioma.
    Tamanna MT; Egbune C
    Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/wt1 axis to regulate non-small cell lung cancer cell malignant behavior.
    Zhu X; Wan J; You X; Yang W; Zhao L
    Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
    RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
    Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
    Shen Q; Liu YX; He Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method.
    Sato Y; Elbadawy M; Suzuki K; Tsunedomi R; Nagano H; Ishihara Y; Yamamoto H; Azakami D; Uchide T; Nabeta R; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Usui T; Sasaki K
    Biomed Pharmacother; 2023 Jun; 162():114651. PubMed ID: 37030135
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outcomes Following treatment with FOLFOX for Patients with Resectable or Potentially Resectable Metastatic Colorectal cancer: A Population-based Cohort Study.
    Habbous S; Tai X; Gill T; Arias J; Beca J; Raphael MJ; Kennedy E; Biagi JJ; Chan KKW
    Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):188-198. PubMed ID: 36610878
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Histopathological and immunohistochemical features of 14 peritoneal mesotheliomas with clinical outcomes and recent updates.
    Karmarkar S; Rekhi B; Deodhar KK; Menon S
    J Cancer Res Ther; 2022; 18(6):1683-1691. PubMed ID: 36412430
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Desmoplastic Small Round Cell Tumor of the Head and Neck: A Clinicopathological, Immunohistochemical and Molecular Analysis of Three Cases with Literature Review.
    Sun M; Shao M; Jiang X; Yin T; Wang Q; Zhao L; Liu J; Lao IW; Yu L; Wang J
    Int J Surg Pathol; 2023 Aug; 31(5):742-750. PubMed ID: 36172631
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multicenter study of diffuse pleural mesothelioma. Histopathological and immunohistochemical features.
    Poleri C; Acosta Haab G; Falcoff N; Guman G; Dalurzo L; Iotti A; Martín ME; Olmedo G; Rayá M; Reginatto A; Werbach A; Demelli G; Labanca MJ; Leguina L; Mora MF
    Medicina (B Aires); 2022; 82(2):210-216. PubMed ID: 35417384
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. wt1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments.
    Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011587
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CD169 Defines Activated CD14
    Affandi AJ; Olesek K; Grabowska J; Nijen Twilhaar MK; Rodríguez E; Saris A; Zwart ES; Nossent EJ; Kalay H; de Kok M; Kazemier G; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Garcia-Vallejo JJ; Storm G; van Kooyk Y; den Haan JMM
    Front Immunol; 2021; 12():697840. PubMed ID: 34394090
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Unravelling the Role of LncRNA wt1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in lung Adenocarcinoma.
    Li W; Liu Y; Li ZJ; Shi Y; Deng J; Bai J; Ma L; Zeng XX; Feng SS; Ren JL; Luo FJ; Rong DY; Chen XQ; Yin HQ; Chen Z; Da F
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540574
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Role of Cytology in the Current Guidelines for Malignant Mesothelioma: Largest Study from India.
    Kaur K; Patel T; Samanta S; Patra S; Trivedi P
    Acta Cytol; 2021; 65(2):175-185. PubMed ID: 33316798
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases.
    Malpica A; Euscher ED; Marques-Piubelli ML; Ferrufino-Schmidt MC; Miranda RN; Sams R; Royal RE; Raghav KPS; Fournier KF; Ramalingam P
    Am J Surg Pathol; 2021 Jan; 45(1):45-58. PubMed ID: 32769428
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
    Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
    Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.
    Zhang W; Lu X; Cui P; Piao C; Xiao M; Liu X; Wang Y; Wu X; Liu J; Yang L
    Cancer Immunol Immunother; 2019 Jan; 68(1):121-130. PubMed ID: 30306202
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic Deletion of
    Sarun KH; Lee K; Williams M; Wright CM; Clarke CJ; Cheng NC; Takahashi K; Cheng YY
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301262
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.